These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
130 related articles for article (PubMed ID: 16611100)
1. Involvement of the transforming growth factor beta in the pathogenesis of hereditary hemorrhagic telangiectasia. Jirillo E; Amati L; Suppressa P; Cirimele D; Guastamacchia E; Covelli V; Tafaro E; Sabbà C Curr Pharm Des; 2006; 12(10):1195-200. PubMed ID: 16611100 [TBL] [Abstract][Full Text] [Related]
2. A hereditary haemorrhagic telangiectasia family with pulmonary involvement is unlinked to the known HHT genes, endoglin and ALK-1. Wallace GM; Shovlin CL Thorax; 2000 Aug; 55(8):685-90. PubMed ID: 10899246 [TBL] [Abstract][Full Text] [Related]
3. Endoglin and alk1 as therapeutic targets for hereditary hemorrhagic telangiectasia. Ruiz-Llorente L; Gallardo-Vara E; Rossi E; Smadja DM; Botella LM; Bernabeu C Expert Opin Ther Targets; 2017 Oct; 21(10):933-947. PubMed ID: 28796572 [TBL] [Abstract][Full Text] [Related]
4. Hereditary haemorrhagic telangiectasia: current views on genetics and mechanisms of disease. Abdalla SA; Letarte M J Med Genet; 2006 Feb; 43(2):97-110. PubMed ID: 15879500 [TBL] [Abstract][Full Text] [Related]
5. Genetic and molecular pathogenesis of hereditary hemorrhagic telangiectasia. Azuma H J Med Invest; 2000 Aug; 47(3-4):81-90. PubMed ID: 11019486 [TBL] [Abstract][Full Text] [Related]
6. Hereditary haemorrhagic telangiectasia: a rare disease as a model for the study of human atherosclerosis. Lenato GM; Suppressa P; Giordano P; Guanti G; Guastamacchia E; Triggiani V; Amati L; Resta F; Covelli V; Jirillo E; Sabbà C Curr Pharm Des; 2007; 13(36):3656-64. PubMed ID: 18220803 [TBL] [Abstract][Full Text] [Related]
7. Patients with hereditary hemorrhagic telangiectasia have increased plasma levels of vascular endothelial growth factor and transforming growth factor-beta1 as well as high ALK1 tissue expression. Sadick H; Riedel F; Naim R; Goessler U; Hörmann K; Hafner M; Lux A Haematologica; 2005 Jun; 90(6):818-28. PubMed ID: 15951295 [TBL] [Abstract][Full Text] [Related]
8. Hereditary hemorrhagic telangiectasia. Genetics, pathogenesis, clinical manifestation and management. Stuhrmann M; El-Harith el-HA Saudi Med J; 2007 Jan; 28(1):11-21. PubMed ID: 17206283 [TBL] [Abstract][Full Text] [Related]
11. Potential role of modifier genes influencing transforming growth factor-beta1 levels in the development of vascular defects in endoglin heterozygous mice with hereditary hemorrhagic telangiectasia. Bourdeau A; Faughnan ME; McDonald ML; Paterson AD; Wanless IR; Letarte M Am J Pathol; 2001 Jun; 158(6):2011-20. PubMed ID: 11395379 [TBL] [Abstract][Full Text] [Related]
12. Hereditary hemorrhagic telangiectasia: an update on transforming growth factor beta signaling in vasculogenesis and angiogenesis. van den Driesche S; Mummery CL; Westermann CJ Cardiovasc Res; 2003 Apr; 58(1):20-31. PubMed ID: 12667943 [TBL] [Abstract][Full Text] [Related]
13. Global gene expression profiling of telangiectasial tissue from patients with hereditary hemorrhagic telangiectasia. Tørring PM; Larsen MJ; Kjeldsen AD; Ousager LB; Tan Q; Brusgaard K Microvasc Res; 2015 May; 99():118-26. PubMed ID: 25892364 [TBL] [Abstract][Full Text] [Related]
14. Clinical and molecular genetic features of pulmonary hypertension in patients with hereditary hemorrhagic telangiectasia. Trembath RC; Thomson JR; Machado RD; Morgan NV; Atkinson C; Winship I; Simonneau G; Galie N; Loyd JE; Humbert M; Nichols WC; Morrell NW; Berg J; Manes A; McGaughran J; Pauciulo M; Wheeler L N Engl J Med; 2001 Aug; 345(5):325-34. PubMed ID: 11484689 [TBL] [Abstract][Full Text] [Related]
15. Analysis of ALK-1 and endoglin in newborns from families with hereditary hemorrhagic telangiectasia type 2. Abdalla SA; Pece-Barbara N; Vera S; Tapia E; Paez E; Bernabeu C; Letarte M Hum Mol Genet; 2000 May; 9(8):1227-37. PubMed ID: 10767348 [TBL] [Abstract][Full Text] [Related]